教職人員
|
沈麗娟
研究領域：蛋白質藥品的修飾與遞送、臨床藥學、健康醫療大資料庫數據分析
本職：教授
| 最高學歷 | : | 1993 School of Pharmacy, National Taiwan University, Taipei, Taiwan (Bachelor of Science) 1995 Program of Hospital Pharmacy, Graduate Institute of Pharmaceutical Sciences, National Taiwan University, Taipei, Taiwan (Master of Science) 2004 Department of Pharmaceutical Sciences, University of Southern California, Los Angeles, U.S.A. (Ph.D., Major in Biochemistry and Pharmaceutics) |
| 經歷 | : | 2017-present Dean, School of Pharmacy, National Taiwan University 2016-present Professor of Graduate Institute of Clinical Pharmacy/School of Pharmacy, College of Medicine, National Taiwan University 2013-2018 Director, Department of Pharmacy, National Taiwan University Hospital 2011-2016 Associate Professor of Graduate Institute of Clinical Pharmacy/School of Pharmacy, College of Medicine, National Taiwan University 2007-2013 Deputy Director, Department of Pharmacy, National Taiwan University Hospital 2005-present Pharmacist, Department of Pharmacy, National Taiwan University Hospital 2005-2011 Assistant Professor of Graduate Institute of Clinical Pharmacy/School of Pharmacy, College of Medicine, National Taiwan University 2004 Senior Scientist, Pfizer Pharmaceutical Company, La Jolla, California, U.S.A 2004 Teaching Assistant, School of Pharmacy, University of Southern California, U.S.A. 2003 Research Assistant, School of Pharmacy, University of Southern California, U.S.A. 1998-2000 Member of Pre-review Non-prescription drugs in National Health Insurance Institute 1997-2000 Preceptor, Clinical Rotated Teaching, Program of Hospital Pharmacy, Graduate Institute of Pharmaceutical Sciences, National Taiwan University 1997-2000 Clinical Pharmacist in Intensive Critical Care Unit, Dept. of Pharmacy, National Taiwan University Hospital 1995-1997 Teaching Assistant, School of Pharmacy, College of Medicine, National Taiwan University |
| 榮譽 | : | 1.99年臺大醫學院青杏醫學獎. 2.100年臺大醫院教學優異個人獎 3.100學年度臺大醫學院教學優良獎 4.101年臺大醫院教材著作優良獎(醫療專業類 團體著作) 5.2013年景康青年教師獎 6.國立臺灣大學健康資料加值應用模式研究計畫，提案競賽第一名。 7.「病人用藥彙編」103年臺大醫院教材著作優良獎(醫療專業類 團體著作) 8.2014年度台灣臨床藥學會優良服務獎得主。 9.103學年度臺灣大學傑出教師獎 |
| 研究領域 | : | 蛋白質藥品的修飾與遞送、臨床藥學、健康醫療大資料庫數據分析 |
| 研究方向 | : | 1. 利用特殊穿胞胜肽片端 HBHAc 作為蛋白藥品運送載體，順利遞送大分子蛋白到細胞內，並經修飾後，增加腫瘤細胞的標靶胞內遞送。 2. 運用藥事行政及藥品管理，推動及建立新型態藥事服務模式，及其經濟效益分析。 3. 利用醫院資料庫及健保資料庫資料，分析藥品上市後使用之有效性及安全性。 |
| 老師的話 | : | 研究以追求真理為目的，以造福人類為依歸 |
| 研究室要求 | : | Science and Humanity |
| 研究室成員 | : | 邱柏全 博士班 2013,8- 張博勛 碩士班 2016,8- 陳冠霖 博士班 2017,8- 過去參與者 陳韻儒 研究助理 2005,7-2006,6 游晧欣 碩士班 2005,8-2007,7 專任研究助理 2007,8-2008,4 張淵琛 碩士班 2005,8-2008,7 林珊而 碩士班 2006,8-2008,7 邱品貴 碩士班 2006,8-2008,12 林珍芳 博士班 2007,8-2012,7 梁玉芬 碩士班 2007,8-2009,7 鄭如辰 碩士班 2007,8-2009,7 黃克理 碩士班 2007,8-2009,7 王竣鋒 碩士班 2008,8-2010,7 邱予芹 碩士班 2008,8-2010,7 黃淑媛 碩士班 2008,8-2011,1 陳瑩倫 碩士班 2009,8-2011,7 孫厚鈞 碩士班 2009,8-2012,7 孫慧恩 碩士班 2010,8-2012,7 康竣崴 碩士班 2010,8-2012,9 林銘彥 碩士班 2010,8-2013,7 葉紫涵 博士班 2010,8-2015,7 陳冠霖 碩士班 2011,8-2013,7 許瀞伊 碩士班 2011,8-2013,7 劉曉軒 碩士班 2011,8-2013,7 陳文衡 碩士班 2011,8-2013,10 吳駿誼 碩士班 2012,8-2015,1 張人予 碩士班 2013,8-2016,7 溫燿駿 碩士班 2014,8-2015,7 黃子藍 碩士班 2014,8-2016,7 謝佩妤 碩士班 2014,8-2017,2 邱賢宗 碩士班 2015,8-2016,7 |
| 招生名額 | : | 製藥科技組：碩士班一名 |
From AI to action: Antimicrobial peptides engineered by generative adversarial networks (GANs)-A novel approach to combat resistant Bacteria
(2025-09-01) Lai, Chia-Wen ; Lin, Chung-Yen ; Tsai, Meng-Chen ; Chen, Wei-Jung ; Hsieh, Chia-Chun ; Lin, Zi-Jing ; LI-JIUAN SHEN ; Chen, Ying-Lien ; Lai, Lee-Jene ; Chen, Shu-Hwa ; Shih, Yang-Hsin
Erratum for previously published articles
(2025-03) WENG-FOUNG HUANG ; JERRY KAI-CHUN FU ; CHEN-HAN CHUEH ; HSIN-HUNG CHEN ; LI-JIUAN SHEN ; YI-WEN TSAI
Interdisciplinary pharmaceutical care model engaging patient participation alleviate the anticholinergic burden in community-dwelling older adults: subgroup analysis of a randomized controlled trial
(2025) Chen, Li-Yu ; Liao, Ling-Chiao ; Chuang, Chin-Ju ; Hsieh, Cheng-Ying ; Huang, Yung-Cheng ; YI-HSUAN YANG ; Chang, Wan-Ting ; Fu, Shau-Huai ; FENG-JUNG YANG ; Chang, Kai-Chieh ; DING-CHENG CHAN ; LI-JIUAN SHEN ; FEI-YUAN HSIAO ; Huang, Yen-Ming ; Hsu, Chih-Cheng ; Wang, Chen-Yu
Pharmaceutical procurement profits and universal health coverage: Reform to a sustainable healthcare and financing system
(2024-11) Huang, Weng-Foung ; Fu, Jerry Kai-Chun ; Chueh, Chen-Han ; Chen, Hsin-Hung ; LI-JIUAN SHEN ; Tsai, Yi-Wen
Sex-specific associations between prolonged serum uric acid levels and risk of major adverse cardiovascular events.
(2024-09) Chien, Hsiu-Ting ; Lin, Yu-Wen ; LI-JIUAN SHEN ; LIAN-YU LIN ; SONG-CHOU HSIEH ; Chen, Yi-An ; FANG-JU LIN
(2025-09-01) Lai, Chia-Wen ; Lin, Chung-Yen ; Tsai, Meng-Chen ; Chen, Wei-Jung ; Hsieh, Chia-Chun ; Lin, Zi-Jing ; LI-JIUAN SHEN ; Chen, Ying-Lien ; Lai, Lee-Jene ; Chen, Shu-Hwa ; Shih, Yang-Hsin
Erratum for previously published articles
(2025-03) WENG-FOUNG HUANG ; JERRY KAI-CHUN FU ; CHEN-HAN CHUEH ; HSIN-HUNG CHEN ; LI-JIUAN SHEN ; YI-WEN TSAI
Interdisciplinary pharmaceutical care model engaging patient participation alleviate the anticholinergic burden in community-dwelling older adults: subgroup analysis of a randomized controlled trial
(2025) Chen, Li-Yu ; Liao, Ling-Chiao ; Chuang, Chin-Ju ; Hsieh, Cheng-Ying ; Huang, Yung-Cheng ; YI-HSUAN YANG ; Chang, Wan-Ting ; Fu, Shau-Huai ; FENG-JUNG YANG ; Chang, Kai-Chieh ; DING-CHENG CHAN ; LI-JIUAN SHEN ; FEI-YUAN HSIAO ; Huang, Yen-Ming ; Hsu, Chih-Cheng ; Wang, Chen-Yu
Pharmaceutical procurement profits and universal health coverage: Reform to a sustainable healthcare and financing system
(2024-11) Huang, Weng-Foung ; Fu, Jerry Kai-Chun ; Chueh, Chen-Han ; Chen, Hsin-Hung ; LI-JIUAN SHEN ; Tsai, Yi-Wen
Sex-specific associations between prolonged serum uric acid levels and risk of major adverse cardiovascular events.
(2024-09) Chien, Hsiu-Ting ; Lin, Yu-Wen ; LI-JIUAN SHEN ; LIAN-YU LIN ; SONG-CHOU HSIEH ; Chen, Yi-An ; FANG-JU LIN
Establish a Novel Model of Pharmaceutical Care via Precision Medicine for Estrogen Receptor (Er) Positive Early Stage Breast Cancer Patients with Oral Tamoxifen Treatment
(2023-08-01～) LI-JIUAN SHEN
Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitor in Patients with Chronic Myeloid Leukemia - Exploration of Precision Medicine in Oral Anticancer Drugs
(2022-08-01～) SHU-WEN LIN
Apply Microfluidic Technology in Oral Formulations of a Protein Drug
(2022-08-01～) LI-JIUAN SHEN
Develop an Oral Formulation of a Monoclonal Antibody for the Treatment of Inflammatory Bowel Disease
(2021-08-01～) LI-JIUAN SHEN
Exploring the Link between Xanthine Oxidase Inhibitors and Risk of Heart Failure: Clinical Validation and Potential Molecular Mechanisms
(2021-08-01～) FANG-JU LIN
(2023-08-01～) LI-JIUAN SHEN
Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitor in Patients with Chronic Myeloid Leukemia - Exploration of Precision Medicine in Oral Anticancer Drugs
(2022-08-01～) SHU-WEN LIN
Apply Microfluidic Technology in Oral Formulations of a Protein Drug
(2022-08-01～) LI-JIUAN SHEN
Develop an Oral Formulation of a Monoclonal Antibody for the Treatment of Inflammatory Bowel Disease
(2021-08-01～) LI-JIUAN SHEN
Exploring the Link between Xanthine Oxidase Inhibitors and Risk of Heart Failure: Clinical Validation and Potential Molecular Mechanisms
(2021-08-01～) FANG-JU LIN